Literature DB >> 2857995

Seroepidemiological study of antibody responses to the zymodemes of Entamoeba histolytica.

T F Jackson, V Gathiram, A E Simjee.   

Abstract

In 303 apparently healthy subjects and 54 patients with confirmed invasive amoebiasis amoebae were isolated where possible, and Entamoeba histolytica was classified into its various zymodems. 20% of the healthy subjects were antibody-positive; 17 healthy subjects proved to be symptomless carriers of pathogenic zymodemes and, like patients with invasive disease, all these were seropositive. Furthermore, of subjects infected with pathogenic zymodemes 94-100% were strongly seropositive, compared with 2-4% of subjects with non-pathogenic zymodemes. Pathogenic zymodemes are therefore believed to be in constant contact with the host's tissues, even in symptom-free individuals; the presence of these potentially invasive organisms is thought to be directly related to the seropositivity in a given population, and seroepidemiological surveys would therefore provide information only on the distribution of this form of the parasite. Quantitative serological data constitute valuable information on the endemicity of an area, and the results will gain reliability from use of two complementary tests instead of one.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2857995     DOI: 10.1016/s0140-6736(85)91262-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Comparison of use of enzyme-linked immunosorbent assay-based kits and PCR amplification of rRNA genes for simultaneous detection of Entamoeba histolytica and E. dispar.

Authors:  D Mirelman; Y Nuchamowitz; T Stolarsky
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

Review 2.  Clinical features and management of amebic liver abscess. Experience from 29 patients.

Authors:  T Weinke; W Scherer; U Neuber; M Trautmann
Journal:  Klin Wochenschr       Date:  1989-04-17

3.  The invasiveness of Entamoeba histolytica - a continuing enigma.

Authors:  J P Ackers
Journal:  Clin Mol Pathol       Date:  1996-08

4.  Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya.

Authors:  H O Pamba; B B Estambale; C N Chunge; L Donno
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Detection of Entamoeba histolytica immunoglobulins G and M to plasma membrane antigen by enzyme-linked immunosorbent assay.

Authors:  M A Sathar; B L Bredenkamp; V Gathiram; A E Simjee; T F Jackson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

6.  Which amoebae are harmful?

Authors:  V K Vinayak
Journal:  Indian J Pediatr       Date:  1985 Sep-Oct       Impact factor: 1.967

7.  Real-time PCR for detection and differentiation of Entamoeba histolytica and Entamoeba dispar in fecal samples.

Authors:  Joerg Blessmann; Heidrun Buss; Phuong A Ton Nu; Binh T Dinh; Quynh T Viet Ngo; An Le Van; Mohamed D Abd Alla; Terry F H G Jackson; Jonathan I Ravdin; Egbert Tannich
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

Review 8.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

9.  Use of a recombinant 170-kilodalton surface antigen of Entamoeba histolytica for serodiagnosis of amebiasis and identification of immunodominant domains of the native molecule.

Authors:  Y Zhang; E Li; T F Jackson; T Zhang; V Gathiram; S L Stanley
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 10.  Amebiasis.

Authors:  D A Bruckner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.